These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 20370551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Targeting Plasmodium liver stages: better late than never.
    Borrmann S, Matuschewski K.
    Trends Mol Med; 2011 Sep; 17(9):527-36. PubMed ID: 21737347
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A, Scorza T, Spithill TW, Smooker PM.
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [Abstract] [Full Text] [Related]

  • 5. Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.
    Bejon P, Kai OK, Mwacharo J, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV.
    Eur J Immunol; 2006 Aug; 36(8):2264-72. PubMed ID: 16856208
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pattern of malaria-specific T-cell responses in a cohort of Ugandan children.
    Ssewanyana I, Pietras C, Baker CA, Nghania F, Jones NG, Rosenthal PJ, Dorsey G, Cao H.
    J Trop Pediatr; 2008 Feb; 54(1):6-13. PubMed ID: 17984125
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Asexual blood-stage malaria vaccine development: facing the challenges.
    Genton B, Reed ZH.
    Curr Opin Infect Dis; 2007 Oct; 20(5):467-75. PubMed ID: 17762779
    [Abstract] [Full Text] [Related]

  • 10. Malaria vaccines: if at first you don't succeed..
    Tongren JE, Zavala F, Roos DS, Riley EM.
    Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671
    [Abstract] [Full Text] [Related]

  • 11. Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations.
    Kats LM, Wang L, Murhandarwati EE, Mitri K, Black CG, Coppel RL.
    Vaccine; 2008 Jun 19; 26(26):3261-7. PubMed ID: 18468741
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea.
    Stirnadel HA, Al-Yaman F, Genton B, Alpers MP, Smith TA.
    Int J Epidemiol; 2000 Jun 19; 29(3):579-86. PubMed ID: 10869334
    [Abstract] [Full Text] [Related]

  • 17. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B.
    Scand J Infect Dis Suppl; 1996 Jun 19; 102():1-53. PubMed ID: 9060051
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 20. Methods for determining vaccine efficacy and effectiveness and the main barriers to developing a fully deployable malaria vaccine.
    Guinovart C, Alonso PL.
    Am J Trop Med Hyg; 2007 Dec 15; 77(6 Suppl):276-81. PubMed ID: 18165503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.